| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. | Director | Common Stock | 45.4K | $771K | $16.99 | Oct 24, 2023 | Direct |
| Centessa Pharmaceuticals plc | Director | Ordinary Shares | 60K | $478K | $7.96 | Nov 18, 2021 | Direct |
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 9.5K | $4.93K | $0.52 | Aug 13, 2024 | Direct |
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.6K | Aug 13, 2024 | Direct | ||
| Tourmaline Bio, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | Aug 13, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Director |
| TRML | Tourmaline Bio, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| AVTX | Avalo Therapeutics, Inc. | Mar 28, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Director |
| TALS | Tourmaline Bio, Inc. | Oct 24, 2023 | 1 | $89K | 4 | Oct 26, 2023 | Director |
| TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 3 | $0 | 4 | Oct 23, 2023 | Director |
| TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 0 | $0 | 3 | Oct 23, 2023 | Director |
| CNTA | Centessa Pharmaceuticals plc | Nov 18, 2021 | 1 | $120K | 4 | Nov 18, 2021 | Director |
| CNTA | Centessa Pharmaceuticals plc | May 27, 2021 | 0 | $0 | 3 | May 27, 2021 | Director |